Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants
Condition: Relapsing Remitting Multiple Sclerosis Intervention: Drug: Natalizumab Sponsor: Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials